Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

Safety and Efficacy of Underwater Endoscopic Mucosal Resection for Type I Gastric Neuroendocrine Tumors Measuring 5-9 mm

NCT07728292 · tracked via the Priya Life Science India tracker
Phase
Not applicable
Started
2026-07-17
Last updated
2026-07-27

Condition(s) studied

Stomach Neuroendocrine Neoplasm

Investigational drug(s) / intervention(s)

Endoscopic mucosal resection under water

Endoscopic mucosal resection under water: * Standard diagnostic gastroscope * Minimal insufflation followed by complete deflation of the gastric lumen * Lumen filled with normal saline to achieve complete submersion of the lesion * Optional marking for flat or ill-defined lesions * Snare capture with a 1-2 mm margin under water * Resection using standardized electrosurgical settings * Defect management (clips or coagulation) at endoscopist discretion * Retrieval of intact specimen * Specimen orientation and pinning on cork for histopathologic assessment

Study summary

Study objectives:

Primary objective:

1.To determine the histologic R0 resection rate of UEMR for type I gastric NETs measuring 5-9 mm.

Secondary objectives:

To evaluate:

1. En bloc resection rate
2. Immediate and delayed adverse events
3. Procedure time
4. Histologic quality of resection (deep and lateral margins)
5. Residual disease at resection scar on surveillance endoscopy oMetachronous gastric NETs during follow-up

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: Patient-level * Age ≥18 years * Fit for endoscopic therapy and sedation * Written informed consent Exclusion Criteria: Lesion-level * Endoscopically visible gastric neuroendocrine tumor * Size 5-9 mm (endoscopic estimation) * Clinical and/or histologic features consistent with type I gastric NET * No endoscopic features suggestive of deep invasion * Technically amenable to snare resection

Primary outcome measure(s)

  • • To determine the histologic R0 resection rate of UEMR for type I gastric NETs measuring 5-9 mm. — 3 months
    No recurrence after 3 months of procedure

Trial sites (1)

FacilityCityRegionStatus
Asian Institute of Gastroenterology/AIG Hospitals Hyderabad Telangana Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07728292 on ClinicalTrials.gov ↗ ← All trials in India